个人简介
教育经历
2003/09-2008/03 复旦大学 生物化学与分子生物学 博士
1994/09-1997/07 中国药科大学 生化药学硕士
1988/09-1992/07 中国药科大学 生物制药 学士
工作经历
1997/07- 现在 复旦大学药学院 讲师
1992/07-1994/08 华北制药集团抗生素研究所助理工程师
研究领域
脂质代谢与代谢性疾病
磷脂代谢与肿瘤及其微环境调控
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Wan, Q., Deng, Y., Huang, Y., Yu, Z., Wang, C., Wang, K., Dong, J., Chen, Y. Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives. ChemistryOpen, 2019;9(2), 176–182.
Chen Y, Dong J, Zhang X, Chen X, Wang L, Chen H, Ge J, Jiang XC. Evacetrapib reduces preβ-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes. Atherosclerosis. 2019 Jun; 285: 147-152.
Yang K, Nong K, Gu Q, Dong J, Wang J. Discovery of N-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model. Eur J Med Chem. 2018 Mar 27; 151: 389-400.
Yang K, Gao B, Ming X, Huang Z, Wang M, Dong J*, Wang J*. Synthesis and evaluation of xanthone derivatives as acid sphingomyelinase inhibitors: potential treatment for UV-induced skin damage. Future Med Chem. 2017 Oct;9(16):1887-1898.
Chen Y#, Dong J#, Chen X, Jiang H, Bakillah A, Zhang X, Li Z, Yin J, Liang D,Zou Y, Hussain M, Cuchel M, Rader D, Chen H, Ge J, Jiang XC. Human serum preβ1-high density lipoprotein levels are independently and negatively associated with coronary artery diseases. Nutr Metab (Lond). 2016 May 17;13:36.
Xue Y, Dong J*, Liang J*. Chinese hamster ovary-sphingomyelin synthase2 biospecific extraction and liquid chromatography with tandem mass spectrometry analysis for the prediction of bioactive components of Rhizoma Polygoni Cuspidati. J Sep Sci. 2016 Mar;39(6):1067-72.